価格表

在庫・価格 : 2025年10月08日 09時12分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Mouse VEGF 164 Affinity Purified Polyclonal Ab
データシート※最新のデータシートでない場合があります
AF-493-SP RSDアールアンドディー システムズ
R&D Systems, Inc.
25 μg ¥28,000 1個 追加

在庫・価格 : 2025年10月08日 09時12分 現在

Anti-Mouse VEGF 164 Affinity Purified Polyclonal Ab

  • 商品コード:AF-493-SP
  • メーカー:RSD
  • 包装:25μg
  • 価格: ¥28,000
  • 在庫:1個
使用文献
No. 文献情報 備考 参照
1 Kobori T et al. Interleukin-18 Amplifies Macrophage Polarization and Morphological Alteration, Leading to Excessive Angiogenesis. Front Immunol 2018;9:334
Kobori T et al
2018/01/01
Species: Mouse, Applications: Neutralization PubMed
2 Xu N et al. Chitinase-3-Like-1 Promotes M2 Macrophage Differentiation and Induces Choroidal Neovascularization in Neovascular Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci 2019 11;60(14):4596-4605
Xu N et al
2019/01/01
Species: Mouse, Applications: In Vivo PubMed
3 Philipp D et al. VEGF Contributes to Mesenchymal Stem Cell-Mediated Reversion of Nor1-Dependent Hypertrophy in iPS Cell-Derived Cardiomyocytes. Stem Cells Int 2021;2021:8888575
Philipp D et al
2021/01/01
Species: Mouse, Applications: Western Blot PubMed
4 Fan Y et al. Serum miRNAs are potential biomarkers for the detection of disc degeneration, among which miR-26a-5p suppresses Smad1 to regulate disc homeostasis. J Cell Mol Med 2019 10;23(10):6679-6689
Fan Y et al
2019/01/01
Species: Mouse, Applications: IHC-P PubMed
5 Li S et al. Cancer immunotherapy via targeted TGF-&#x3B2; signalling blockade in T<sub>H</sub> cells. Nature 2020 11;587(7832):121-125
Li S et al
2020/01/01
Species: Mouse, Applications: IHC PubMed
6 Zheng Q et al. Overexpression of microRNA-367 inhibits angiogenesis in ovarian cancer by downregulating the expression of LPA1. Cancer Cell Int 2020;20:476
Zheng Q et al
2020/01/01
Species: Human, Applications: Western Blot PubMed
7 Ichikawa K et al. Activated FGF2 signaling pathway in tumor vasculature is essential for acquired resistance to anti-VEGF therapy. Sci Rep 2020 02;10(1):2939
Ichikawa K et al
2020/01/01
Species: Mouse, Applications: Western Blot PubMed
8 Mulcrone PL et al. Osteocyte Vegf-a contributes to myeloma-associated angiogenesis and is regulated by Fgf23. Sci Rep 2020 10;10(1):17319
Mulcrone PL et al
2020/01/01
Species: Human, Applications: Neutralization PubMed
9 Lee YJ et al. RhoA/phosphatidylinositol 3-kinase/protein kinase B/mitogen-activated protein kinase signaling after growth arrest-specific protein 6/mer receptor tyrosine kinase engagement promotes epithelial cell growth and wound repair via upregulation o
Lee YJ et al
2014/01/01
Species: Mouse, Applications: Neutralization PubMed
10 Jujo K et al. CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction. Proc. Natl. Acad. Sci. U.S.A. 2010 Jun;107(24):11008-13
Jujo K et al
2010/01/01
Species: Mouse, Applications: Neutralization PubMed
11 Zheng L et al. PDGF-CC underlies resistance to VEGF-A inhibition and combinatorial targeting of both suppresses pathological angiogenesis more efficiently. Oncotarget 2016 Nov;7(47):77902-77915
Zheng L et al
2016/01/01
Species: Mouse, Applications: Neutralization PubMed
12 Sprague L et al. Dendritic cells: In vitro culture in two- and three-dimensional collagen systems and expression of collagen receptors in tumors and atherosclerotic microenvironments. Exp. Cell Res. 2014 Apr;323(1):7-27
Sprague L et al
2014/01/01
Species: Mouse, Applications: ELISA Development (Detection) PubMed
13 Yu S et al. Fatty acid-binding protein 5 (FABP5) regulates cognitive function both by decreasing anandamide levels and by activating the nuclear receptor peroxisome proliferator-activated receptor &#x3B2;/&#x3B4; (PPAR&#x3B2;/&#x3B4;) in the brain. J. Bio
Yu S et al
2014/01/01
Species: Mouse, Applications: Western Blot PubMed
14 Hakroush S et al. Effects of increased renal tubular vascular endothelial growth factor (VEGF) on fibrosis, cyst formation, and glomerular disease. Am. J. Pathol. 2009 Nov;175(5):1883-95
Hakroush S et al
2009/01/01
Species: Mouse, Applications: IHC-P PubMed
15 Locatelli M et al. Shiga toxin promotes podocyte injury in experimental hemolytic uremic syndrome via activation of the alternative pathway of complement. J. Am. Soc. Nephrol. 2014 Aug;25(8):1786-98
Locatelli M et al
2014/01/01
Species: Mouse, Applications: IHC PubMed
16 Le Bras B et al. VEGF-C is a trophic factor for neural progenitors in the vertebrate embryonic brain. Nat. Neurosci. 2006 Mar;9(3):340-8
Le Bras B et al
2006/01/01
Species: Mouse, Applications: IHC-Fr PubMed
17 Liu J et al. Relationship between complement membrane attack complex, chemokine (C-C motif) ligand 2 (CCL2) and vascular endothelial growth factor in mouse model of laser-induced choroidal neovascularization. J. Biol. Chem. 2011 Jun;286(23):20991-1001
Liu J et al
2011/01/01
Species: Mouse, Applications: Neutralization PubMed
18 Shen HC et al. Recapitulation of pancreatic neuroendocrine tumors in human multiple endocrine neoplasia type I syndrome via Pdx1-directed inactivation of Men1. Cancer Res. 2009 Mar;69(5):1858-66
Shen HC et al
2009/01/01
Species: Mouse, Applications: IHC-Fr PubMed
19 Di Bernardini E et al. Endothelial lineage differentiation from induced pluripotent stem cells is regulated by microRNA-21 and transforming growth factor &#x3B2;2 (TGF-&#x3B2;2) pathways. J. Biol. Chem. 2014 Feb;289(6):3383-93
Di Bernardini E et al
2014/01/01
Species: Mouse, Applications: Neutralization PubMed
20 Sitaras N et al. Retinal neurons curb inflammation and enhance revascularization in ischemic retinopathies via proteinase-activated receptor-2. Am. J. Pathol. 2015 Feb;185(2):581-95
Sitaras N et al
2015/01/01
Species: Mouse, Applications: Neutralization PubMed
21 Ponticelli S et al. Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1. J. Biol. Chem. 2008 Dec;283(49):34250-9
Ponticelli S et al
2008/01/01
Species: Mouse, Applications: ELISA Development PubMed
22 Lederle W et al. Platelet-derived growth factor-B normalizes micromorphology and vessel function in vascular endothelial growth factor-A-induced squamous cell carcinomas. Am. J. Pathol. 2010 Feb;176(2):981-94
Lederle W et al
2010/01/01
Species: Mouse, Applications: ICC PubMed
23 Runge A et al. An inducible hepatocellular carcinoma model for preclinical evaluation of antiangiogenic therapy in adult mice. Cancer Res. 2014 Aug;74(15):4157-69
Runge A et al
2014/01/01
Species: Mouse, Applications: IHC-P PubMed
24 Furrer K et al. Serotonin reverts age-related capillarization and failure of regeneration in the liver through a VEGF-dependent pathway. Proc. Natl. Acad. Sci. U.S.A. 2011 Feb;108(7):2945-50
Furrer K et al
2011/01/01
Species: Mouse, Applications: Neutralization PubMed
25 Basavarajappa HD et al. Ferrochelatase is a therapeutic target for ocular neovascularization. EMBO Mol Med 2017 Jun;9(6):786-801
Basavarajappa HD et al
2017/01/01
Species: Mouse, Applications: Functional Assay PubMed
26 Lee J et al. Angiopoietin-1 suppresses choroidal neovascularization and vascular leakage. Invest. Ophthalmol. Vis. Sci. 2014 Apr;55(4):2191-9
Lee J et al
2014/01/01
Species: Mouse, Applications: Western Blot PubMed
27 Raghuwanshi SK et al. G protein-coupled receptor kinase 6 deficiency promotes angiogenesis, tumor progression, and metastasis. J. Immunol. 2013 May;190(10):5329-36
Raghuwanshi SK et al
2013/01/01
Species: Mouse, Applications: ELISA Development (Capture) PubMed
28 Ding J et al. Bushen Huoxue Recipe Alleviates Implantation Loss in Mice by Enhancing Estrogen-Progesterone Signals and Promoting Decidual Angiogenesis Through FGF2 During Early Pregnancy. Front Pharmacol 2018;9:437
Ding J et al
2018/01/01
Species: Mouse, Applications: Western Blot PubMed
29 Chen XW et al. CYP4A in tumor-associated macrophages promotes pre-metastatic niche formation and metastasis. Oncogene 2017 Aug;36(35):5045-5057
Chen XW et al
2017/01/01
Species: Mouse, Applications: Functional Assay PubMed
30 Subileau M et al. Bone Morphogenetic Protein 9 Regulates Early Lymphatic-Specified Endothelial Cell Expansion during Mouse Embryonic Stem Cell Differentiation. Stem Cell Reports 2019 Jan;12(1):98-111
Subileau M et al
2019/01/01
Species: Mouse, Applications: Neutralization PubMed
31 Nozaki M et al. Loss of SPARC-mediated VEGFR-1 suppression after injury reveals a novel antiangiogenic activity of VEGF-A. J. Clin. Invest. 2006 Feb;116(2):422-9
Nozaki M et al
2006/01/01
Species: Mouse, Applications: Neutralization PubMed
32 Chen J et al. Modulation of Salmonella Tumor-Colonization and Intratumoral Anti-angiogenesis by Triptolide and Its Mechanism. Theranostics 2017;7(8):2250-2260
Chen J et al
2017/01/01
Species: Mouse, Applications: Neutralization PubMed
33 Kataru RP et al. Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution. Blood 2009 May;113(22):5650-9
Kataru RP et al
2009/01/01
Species: Mouse, Applications: Neutralization PubMed
34 Zhang M et al. Response patterns of cytokines/chemokines in two murine strains after irradiation. Cytokine 2012 May;58(2):169-77
Zhang M et al
2012/01/01
Species: Mouse, Applications: Luminex Development PubMed
35 Tan KW et al. Neutrophils contribute to inflammatory lymphangiogenesis by increasing VEGF-A bioavailability and secreting VEGF-D. Blood 2013 Nov;122(22):3666-77
Tan KW et al
2013/01/01
Species: Mouse, Applications: Neutralization PubMed
36 Hara T et al. Control of metastatic niche formation by targeting APBA3/Mint3 in inflammatory monocytes. Proc. Natl. Acad. Sci. U.S.A. 2017 May;114(22):E4416-E4424
Hara T et al
2017/01/01
Species: Mouse, Applications: Neutralization PubMed
37 Gabrilovich DI et al. Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function. Clin. Cancer Res. 1999 Oct;5(10):2963-70
Gabrilovich DI et al
1999/01/01
Species: Mouse, Applications: Neutralization PubMed
38 Blouw B et al. Loss of vascular endothelial growth factor expression reduces vascularization, but not growth, of tumors lacking the Von Hippel-Lindau tumor suppressor gene. Oncogene 2007 Jul;26(31):4531-40
Blouw B et al
2007/01/01
Species: Mouse, Applications: IHC PubMed
39 Dikov MM et al. Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiation. J. Immunol. 2005 Jan;174(1):215-22
Dikov MM et al
2005/01/01
Species: Mouse, Applications: Neutralization PubMed
40 Reina-Torres E et al. VEGF as a Paracrine Regulator of Conventional Outflow Facility. Invest. Ophthalmol. Vis. Sci. 2017 Mar;58(3):1899-1908
Reina-Torres E et al
2017/01/01
Species: Mouse, Applications: IHC PubMed
41 Balser C et al. Co-inhibition of PGF and VEGF blocks their expression in mononuclear phagocytes and limits neovascularization and leakage in the murine retina. J Neuroinflammation 2019 Feb;16(1):26
Balser C et al
2019/01/01
Species: Mouse, Applications: Neutralization PubMed
42 Carmi Y et al. The Role of IL-1&#x3B2; in the Early Tumor Cell-Induced Angiogenic Response. J. Immunol. 2013 Apr;190(7):3500-9
Carmi Y et al
2013/01/01
Species: Mouse, Applications: Neutralization PubMed
43 Zhao C et al. Endothelial Cords Promote Tumor Initial Growth prior to Vascular Function through a Paracrine Mechanism. Sci Rep 2016 Jan;6:19404
Zhao C et al
2016/01/01
Species: Human, Applications: Neutralization PubMed
44 Oe Y et al. Protease-activated receptor 2 protects against VEGF inhibitor-induced glomerular endothelial and podocyte injury. Sci Rep 2019 Feb;9(1):2986
Oe Y et al
2019/01/01
Species: Mouse, Applications: IHC-P PubMed
45 Zeng L et al. MicroRNA-210 overexpression induces angiogenesis and neurogenesis in the normal adult mouse brain. Gene Ther. 2014 Jan;21(1):37-43
Zeng L et al
2014/01/01
Species: Mouse, Applications: IHC PubMed
46 Kolb AD et al. Osteoblasts are &quot;educated&quot; by crosstalk with metastatic breast cancer cells in the bone tumor microenvironment. Breast Cancer Res. 2019 02;21(1):31
Kolb AD et al
2019/01/01
Species: Mouse, Applications: Western Blot PubMed
47 Lederle W et al. Platelet-derived growth factor-BB controls epithelial tumor phenotype by differential growth factor regulation in stromal cells. Am. J. Pathol. 2006 Nov;169(5):1767-83
Lederle W et al
2006/01/01
Species: Mouse, Applications: IHC PubMed
48 Bock F et al. Safety profile of topical VEGF neutralization at the cornea. Invest. Ophthalmol. Vis. Sci. 2009 May;50(5):2095-102
Bock F et al
2009/01/01
Species: Mouse, Applications: Blocking PubMed
49 Matsuno H et al. Lack of alpha2-antiplasmin promotes pulmonary heart failure via overrelease of VEGF after acute myocardial infarction. Blood 2002 Oct;100(7):2487-93
Matsuno H et al
2002/01/01
Species: Mouse, Applications: Neutralization PubMed
50 Valc叩rcel M et al. IL-18 regulates melanoma VLA-4 integrin activation through a Hierarchized sequence of inflammatory factors. J. Invest. Dermatol. 2014 Feb;134(2):470-80
Valc叩rcel M et al
2014/01/01
Species: Mouse, Applications: Neutralization PubMed
51 Katsube K et al. Vascular endothelial growth factor (VEGF) gene transfer enhances surgical revascularization of necrotic bone. J. Orthop. Res. 2005 Mar;23(2):469-74
Katsube K et al
2005/01/01
Species: Rabbit, Applications: IHC PubMed
52 Banerjee K et al. CXCR2-/- mice show enhanced susceptibility to herpetic stromal keratitis: a role for IL-6-induced neovascularization. J. Immunol. 2004 Jan;172(2):1237-45
Banerjee K et al
2004/01/01
Species: Mouse, Applications: Neutralization PubMed
53 Lee E et al. Breast cancer cells condition lymphatic endothelial cells within pre-metastatic niches to promote metastasis. Nat Commun 2014;5:4715
Lee E et al
2014/01/01
Species: Mouse, Applications: Neutralization PubMed
54 Nishida Y et al. Vascularization via activation of VEGF-VEGFR signaling is essential for peripheral nerve regeneration. Biomed. Res. 2018;39(6):287-294
Nishida Y et al
2018/01/01
Species: Mouse, Applications: Neutralization PubMed
55 Schrand B et al. Hapten-mediated recruitment of polyclonal antibodies to tumors engenders antitumor immunity. Nat Commun 2018 08;9(1):3348
Schrand B et al
2018/01/01
Species: Mouse, Applications: IHC PubMed
56 Hendel A et al. Granzyme B releases vascular endothelial growth factor from extracellular matrix and induces vascular permeability. Lab. Invest. 2014 Jul;94(7):716-25
Hendel A et al
2014/01/01
Species: Mouse, Applications: Neutralization PubMed
57 Kim B et al. Application of plasmid DNA encoding IL-18 diminishes development of herpetic stromal keratitis by antiangiogenic effects. J. Immunol. 2005 Jul;175(1):509-16
Kim B et al
2005/01/01
Species: Mouse, Applications: ELISA Development PubMed
58 Chyou S et al. Fibroblast-type reticular stromal cells regulate the lymph node vasculature. J. Immunol. 2008 Sep;181(6):3887-96
Chyou S et al
2008/01/01
Species: Mouse, Applications: Neutralization PubMed
59 Bonapace L et al. Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis. Nature 2014 Nov;515(7525):130-3
Bonapace L et al
2014/01/01
Species: Mouse, Applications: PubMed
60 Cahill RA et al. Mast cells facilitate local VEGF release as an early event in the pathogenesis of postoperative peritoneal adhesions. Surgery 2006 Jul;140(1):108-12
Cahill RA et al
2006/01/01
Species: Mouse, Applications: Neutralization PubMed
61 Adrian-Segarra JM et al. The AB loop of oncostatin M (OSM) determines species-specific signaling in humans and mice. J. Biol. Chem. 2018 12;293(52):20181-20199
Adrian-Segarra JM et al
2018/01/01
Species: Human, Applications: Western Blot PubMed
62 Shchors K et al. The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1beta. Genes Dev. 2006 Sep;20(18):2527-38
Shchors K et al
2006/01/01
Species: Mouse, Applications: ELISA Development PubMed
63 Nakayama T et al. Regeneration-associated cell transplantation contributes to tissue recovery in mice with acute ischemic stroke. PLoS ONE 2019;14(1):e0210198
Nakayama T et al
2019/01/01
Species: Mouse, Applications: IHC PubMed
64 Kodama I et al. Estrogen regulates the production of VEGF for osteoclast formation and activity in op/op mice. J. Bone Miner. Res. 2004 Feb;19(2):200-6
Kodama I et al
2004/01/01
Species: Mouse, Applications: Neutralization PubMed
65 John B et al. Regulation of the bi-directional cross-talk between ovarian cancer cells and adipocytes by SPARC. Oncogene 2019 May;38(22):4366-4383
John B et al
2019/01/01
Species: Mouse, Applications: Neutralization PubMed
66 Pushpakumar SB et al. Folic acid mitigates angiotensin-II-induced blood pressure and renal remodeling. PLoS ONE 2013;8(12):e83813
Pushpakumar SB et al
2013/01/01
Species: Mouse, Applications: Western Blot PubMed
67 Kajiya K et al. Vascular endothelial growth factor-A mediates ultraviolet B-induced impairment of lymphatic vessel function. Am. J. Pathol. 2006 Oct;169(4):1496-503
Kajiya K et al
2006/01/01
Species: Mouse, Applications: Neutralization PubMed
68 Lu H et al. IKK2 inhibition attenuates laser-induced choroidal neovascularization. PLoS ONE 2014;9(1):e87530
Lu H et al
2014/01/01
Species: Mouse, Applications: Neutralization PubMed
69 Sun JL et al. Intrafibrillar silicified collagen scaffold modulates monocyte to promote cell homing, angiogenesis and bone regeneration. Biomaterials 2017 01;113:203-216
Sun JL et al
2017/01/01
Species: Mouse, Applications: Neutralization PubMed
70 Wilgus TA et al. Regulation of scar formation by vascular endothelial growth factor. Lab. Invest. 2008 Jun;88(6):579-90
Wilgus TA et al
2008/01/01
Species: Mouse, Applications: Neutralization PubMed
71 Tashiro Y et al. Inhibition of PAI-1 induces neutrophil-driven neoangiogenesis and promotes tissue regeneration via production of angiocrine factors in mice. Blood 2012 Jun;119(26):6382-93
Tashiro Y et al
2012/01/01
Species: Mouse, Applications: In Vivo PubMed
72 Limani P et al. Antihypoxic Potentiation of Standard Therapy for Experimental Colorectal Liver Metastasis through Myo-Inositol Trispyrophosphate. Clin. Cancer Res. 2016 Dec;22(23):5887-5897
Limani P et al
2016/01/01
Species: Mouse, Applications: Neutralization PubMed
73 Saint-Geniez M et al. Role of cell and matrix-bound VEGF isoforms in lens development. Invest. Ophthalmol. Vis. Sci. 2009 Jan;50(1):311-21
Saint-Geniez M et al
2009/01/01
Species: Mouse, Applications: Neutralization PubMed
74 Wang H et al. Retinal pigment epithelial cell expression of active Rap 1a by scAAV2 inhibits choroidal neovascularization. Mol Ther Methods Clin Dev 2016;3:16056
Wang H et al
2016/01/01
Species: Mouse, Applications: Neutralization PubMed
75 Li Z et al. IL-17 and VEGF are necessary for efficient corneal nerve regeneration. Am. J. Pathol. 2011 Mar;178(3):1106-16
Li Z et al
2011/01/01
Species: Mouse, Applications: Neutralization PubMed
76 Park SY et al. HMGB1 induces angiogenesis in rheumatoid arthritis via HIF-1&#x3B1; activation. Eur. J. Immunol. 2015 Apr;45(4):1216-27
Park SY et al
2015/01/01
Species: Mouse, Applications: IHC-P PubMed
77 Wuest TR et al. VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis. J. Exp. Med. 2010 Jan;207(1):101-15
Wuest TR et al
2010/01/01
Species: Mouse, Applications: Neutralization PubMed
78 Khabbazi S et al. Morphine decreases the pro-angiogenic interaction between breast cancer cells and macrophages in vitro. Sci Rep 2016 Aug;6:31572
Khabbazi S et al
2016/01/01
Species: Mouse, Applications: Neutralization PubMed
79 Morita A et al. A delay in vascularization induces abnormal astrocyte proliferation and migration in the mouse retina. Dev. Dyn. 2017 03;246(3):186-200
Morita A et al
2017/01/01
Species: Mouse, Applications: IHC-Fr PubMed
80 Sulaiman RS et al. A novel small molecule ameliorates ocular neovascularisation and synergises with anti-VEGF therapy. Sci Rep 2016 May;6:25509
Sulaiman RS et al
2016/01/01
Species: Mouse, Applications: Neutralization PubMed
81 Kragl M et al. The biomechanical properties of an epithelial tissue determine the location of its vasculature. Nat Commun 2016 Dec;7:13560
Kragl M et al
2016/01/01
Species: Mouse, Applications: IHC PubMed
  • No.: 1
  • 文献情報:
    Kobori T et al. Interleukin-18 Amplifies Macrophage Polarization and Morphological Alteration, Leading to Excessive Angiogenesis. Front Immunol 2018;9:334
    Kobori T et al
    2018/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Xu N et al. Chitinase-3-Like-1 Promotes M2 Macrophage Differentiation and Induces Choroidal Neovascularization in Neovascular Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci 2019 11;60(14):4596-4605
    Xu N et al
    2019/01/01
  • 備考:
    Species: Mouse, Applications: In Vivo
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Philipp D et al. VEGF Contributes to Mesenchymal Stem Cell-Mediated Reversion of Nor1-Dependent Hypertrophy in iPS Cell-Derived Cardiomyocytes. Stem Cells Int 2021;2021:8888575
    Philipp D et al
    2021/01/01
  • 備考:
    Species: Mouse, Applications: Western Blot
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Fan Y et al. Serum miRNAs are potential biomarkers for the detection of disc degeneration, among which miR-26a-5p suppresses Smad1 to regulate disc homeostasis. J Cell Mol Med 2019 10;23(10):6679-6689
    Fan Y et al
    2019/01/01
  • 備考:
    Species: Mouse, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Li S et al. Cancer immunotherapy via targeted TGF-&#x3B2; signalling blockade in T<sub>H</sub> cells. Nature 2020 11;587(7832):121-125
    Li S et al
    2020/01/01
  • 備考:
    Species: Mouse, Applications: IHC
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Zheng Q et al. Overexpression of microRNA-367 inhibits angiogenesis in ovarian cancer by downregulating the expression of LPA1. Cancer Cell Int 2020;20:476
    Zheng Q et al
    2020/01/01
  • 備考:
    Species: Human, Applications: Western Blot
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Ichikawa K et al. Activated FGF2 signaling pathway in tumor vasculature is essential for acquired resistance to anti-VEGF therapy. Sci Rep 2020 02;10(1):2939
    Ichikawa K et al
    2020/01/01
  • 備考:
    Species: Mouse, Applications: Western Blot
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Mulcrone PL et al. Osteocyte Vegf-a contributes to myeloma-associated angiogenesis and is regulated by Fgf23. Sci Rep 2020 10;10(1):17319
    Mulcrone PL et al
    2020/01/01
  • 備考:
    Species: Human, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Lee YJ et al. RhoA/phosphatidylinositol 3-kinase/protein kinase B/mitogen-activated protein kinase signaling after growth arrest-specific protein 6/mer receptor tyrosine kinase engagement promotes epithelial cell growth and wound repair via upregulation o
    Lee YJ et al
    2014/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Jujo K et al. CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction. Proc. Natl. Acad. Sci. U.S.A. 2010 Jun;107(24):11008-13
    Jujo K et al
    2010/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Zheng L et al. PDGF-CC underlies resistance to VEGF-A inhibition and combinatorial targeting of both suppresses pathological angiogenesis more efficiently. Oncotarget 2016 Nov;7(47):77902-77915
    Zheng L et al
    2016/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Sprague L et al. Dendritic cells: In vitro culture in two- and three-dimensional collagen systems and expression of collagen receptors in tumors and atherosclerotic microenvironments. Exp. Cell Res. 2014 Apr;323(1):7-27
    Sprague L et al
    2014/01/01
  • 備考:
    Species: Mouse, Applications: ELISA Development (Detection)
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Yu S et al. Fatty acid-binding protein 5 (FABP5) regulates cognitive function both by decreasing anandamide levels and by activating the nuclear receptor peroxisome proliferator-activated receptor &#x3B2;/&#x3B4; (PPAR&#x3B2;/&#x3B4;) in the brain. J. Bio
    Yu S et al
    2014/01/01
  • 備考:
    Species: Mouse, Applications: Western Blot
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Hakroush S et al. Effects of increased renal tubular vascular endothelial growth factor (VEGF) on fibrosis, cyst formation, and glomerular disease. Am. J. Pathol. 2009 Nov;175(5):1883-95
    Hakroush S et al
    2009/01/01
  • 備考:
    Species: Mouse, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Locatelli M et al. Shiga toxin promotes podocyte injury in experimental hemolytic uremic syndrome via activation of the alternative pathway of complement. J. Am. Soc. Nephrol. 2014 Aug;25(8):1786-98
    Locatelli M et al
    2014/01/01
  • 備考:
    Species: Mouse, Applications: IHC
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Le Bras B et al. VEGF-C is a trophic factor for neural progenitors in the vertebrate embryonic brain. Nat. Neurosci. 2006 Mar;9(3):340-8
    Le Bras B et al
    2006/01/01
  • 備考:
    Species: Mouse, Applications: IHC-Fr
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Liu J et al. Relationship between complement membrane attack complex, chemokine (C-C motif) ligand 2 (CCL2) and vascular endothelial growth factor in mouse model of laser-induced choroidal neovascularization. J. Biol. Chem. 2011 Jun;286(23):20991-1001
    Liu J et al
    2011/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Shen HC et al. Recapitulation of pancreatic neuroendocrine tumors in human multiple endocrine neoplasia type I syndrome via Pdx1-directed inactivation of Men1. Cancer Res. 2009 Mar;69(5):1858-66
    Shen HC et al
    2009/01/01
  • 備考:
    Species: Mouse, Applications: IHC-Fr
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Di Bernardini E et al. Endothelial lineage differentiation from induced pluripotent stem cells is regulated by microRNA-21 and transforming growth factor &#x3B2;2 (TGF-&#x3B2;2) pathways. J. Biol. Chem. 2014 Feb;289(6):3383-93
    Di Bernardini E et al
    2014/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Sitaras N et al. Retinal neurons curb inflammation and enhance revascularization in ischemic retinopathies via proteinase-activated receptor-2. Am. J. Pathol. 2015 Feb;185(2):581-95
    Sitaras N et al
    2015/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Ponticelli S et al. Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1. J. Biol. Chem. 2008 Dec;283(49):34250-9
    Ponticelli S et al
    2008/01/01
  • 備考:
    Species: Mouse, Applications: ELISA Development
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Lederle W et al. Platelet-derived growth factor-B normalizes micromorphology and vessel function in vascular endothelial growth factor-A-induced squamous cell carcinomas. Am. J. Pathol. 2010 Feb;176(2):981-94
    Lederle W et al
    2010/01/01
  • 備考:
    Species: Mouse, Applications: ICC
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Runge A et al. An inducible hepatocellular carcinoma model for preclinical evaluation of antiangiogenic therapy in adult mice. Cancer Res. 2014 Aug;74(15):4157-69
    Runge A et al
    2014/01/01
  • 備考:
    Species: Mouse, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Furrer K et al. Serotonin reverts age-related capillarization and failure of regeneration in the liver through a VEGF-dependent pathway. Proc. Natl. Acad. Sci. U.S.A. 2011 Feb;108(7):2945-50
    Furrer K et al
    2011/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Basavarajappa HD et al. Ferrochelatase is a therapeutic target for ocular neovascularization. EMBO Mol Med 2017 Jun;9(6):786-801
    Basavarajappa HD et al
    2017/01/01
  • 備考:
    Species: Mouse, Applications: Functional Assay
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Lee J et al. Angiopoietin-1 suppresses choroidal neovascularization and vascular leakage. Invest. Ophthalmol. Vis. Sci. 2014 Apr;55(4):2191-9
    Lee J et al
    2014/01/01
  • 備考:
    Species: Mouse, Applications: Western Blot
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Raghuwanshi SK et al. G protein-coupled receptor kinase 6 deficiency promotes angiogenesis, tumor progression, and metastasis. J. Immunol. 2013 May;190(10):5329-36
    Raghuwanshi SK et al
    2013/01/01
  • 備考:
    Species: Mouse, Applications: ELISA Development (Capture)
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Ding J et al. Bushen Huoxue Recipe Alleviates Implantation Loss in Mice by Enhancing Estrogen-Progesterone Signals and Promoting Decidual Angiogenesis Through FGF2 During Early Pregnancy. Front Pharmacol 2018;9:437
    Ding J et al
    2018/01/01
  • 備考:
    Species: Mouse, Applications: Western Blot
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Chen XW et al. CYP4A in tumor-associated macrophages promotes pre-metastatic niche formation and metastasis. Oncogene 2017 Aug;36(35):5045-5057
    Chen XW et al
    2017/01/01
  • 備考:
    Species: Mouse, Applications: Functional Assay
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Subileau M et al. Bone Morphogenetic Protein 9 Regulates Early Lymphatic-Specified Endothelial Cell Expansion during Mouse Embryonic Stem Cell Differentiation. Stem Cell Reports 2019 Jan;12(1):98-111
    Subileau M et al
    2019/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Nozaki M et al. Loss of SPARC-mediated VEGFR-1 suppression after injury reveals a novel antiangiogenic activity of VEGF-A. J. Clin. Invest. 2006 Feb;116(2):422-9
    Nozaki M et al
    2006/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Chen J et al. Modulation of Salmonella Tumor-Colonization and Intratumoral Anti-angiogenesis by Triptolide and Its Mechanism. Theranostics 2017;7(8):2250-2260
    Chen J et al
    2017/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Kataru RP et al. Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution. Blood 2009 May;113(22):5650-9
    Kataru RP et al
    2009/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Zhang M et al. Response patterns of cytokines/chemokines in two murine strains after irradiation. Cytokine 2012 May;58(2):169-77
    Zhang M et al
    2012/01/01
  • 備考:
    Species: Mouse, Applications: Luminex Development
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Tan KW et al. Neutrophils contribute to inflammatory lymphangiogenesis by increasing VEGF-A bioavailability and secreting VEGF-D. Blood 2013 Nov;122(22):3666-77
    Tan KW et al
    2013/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 36
  • 文献情報:
    Hara T et al. Control of metastatic niche formation by targeting APBA3/Mint3 in inflammatory monocytes. Proc. Natl. Acad. Sci. U.S.A. 2017 May;114(22):E4416-E4424
    Hara T et al
    2017/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 37
  • 文献情報:
    Gabrilovich DI et al. Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function. Clin. Cancer Res. 1999 Oct;5(10):2963-70
    Gabrilovich DI et al
    1999/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 38
  • 文献情報:
    Blouw B et al. Loss of vascular endothelial growth factor expression reduces vascularization, but not growth, of tumors lacking the Von Hippel-Lindau tumor suppressor gene. Oncogene 2007 Jul;26(31):4531-40
    Blouw B et al
    2007/01/01
  • 備考:
    Species: Mouse, Applications: IHC
  • 参照:
    PubMed
  • No.: 39
  • 文献情報:
    Dikov MM et al. Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiation. J. Immunol. 2005 Jan;174(1):215-22
    Dikov MM et al
    2005/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 40
  • 文献情報:
    Reina-Torres E et al. VEGF as a Paracrine Regulator of Conventional Outflow Facility. Invest. Ophthalmol. Vis. Sci. 2017 Mar;58(3):1899-1908
    Reina-Torres E et al
    2017/01/01
  • 備考:
    Species: Mouse, Applications: IHC
  • 参照:
    PubMed
  • No.: 41
  • 文献情報:
    Balser C et al. Co-inhibition of PGF and VEGF blocks their expression in mononuclear phagocytes and limits neovascularization and leakage in the murine retina. J Neuroinflammation 2019 Feb;16(1):26
    Balser C et al
    2019/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 42
  • 文献情報:
    Carmi Y et al. The Role of IL-1&#x3B2; in the Early Tumor Cell-Induced Angiogenic Response. J. Immunol. 2013 Apr;190(7):3500-9
    Carmi Y et al
    2013/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 43
  • 文献情報:
    Zhao C et al. Endothelial Cords Promote Tumor Initial Growth prior to Vascular Function through a Paracrine Mechanism. Sci Rep 2016 Jan;6:19404
    Zhao C et al
    2016/01/01
  • 備考:
    Species: Human, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 44
  • 文献情報:
    Oe Y et al. Protease-activated receptor 2 protects against VEGF inhibitor-induced glomerular endothelial and podocyte injury. Sci Rep 2019 Feb;9(1):2986
    Oe Y et al
    2019/01/01
  • 備考:
    Species: Mouse, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 45
  • 文献情報:
    Zeng L et al. MicroRNA-210 overexpression induces angiogenesis and neurogenesis in the normal adult mouse brain. Gene Ther. 2014 Jan;21(1):37-43
    Zeng L et al
    2014/01/01
  • 備考:
    Species: Mouse, Applications: IHC
  • 参照:
    PubMed
  • No.: 46
  • 文献情報:
    Kolb AD et al. Osteoblasts are &quot;educated&quot; by crosstalk with metastatic breast cancer cells in the bone tumor microenvironment. Breast Cancer Res. 2019 02;21(1):31
    Kolb AD et al
    2019/01/01
  • 備考:
    Species: Mouse, Applications: Western Blot
  • 参照:
    PubMed
  • No.: 47
  • 文献情報:
    Lederle W et al. Platelet-derived growth factor-BB controls epithelial tumor phenotype by differential growth factor regulation in stromal cells. Am. J. Pathol. 2006 Nov;169(5):1767-83
    Lederle W et al
    2006/01/01
  • 備考:
    Species: Mouse, Applications: IHC
  • 参照:
    PubMed
  • No.: 48
  • 文献情報:
    Bock F et al. Safety profile of topical VEGF neutralization at the cornea. Invest. Ophthalmol. Vis. Sci. 2009 May;50(5):2095-102
    Bock F et al
    2009/01/01
  • 備考:
    Species: Mouse, Applications: Blocking
  • 参照:
    PubMed
  • No.: 49
  • 文献情報:
    Matsuno H et al. Lack of alpha2-antiplasmin promotes pulmonary heart failure via overrelease of VEGF after acute myocardial infarction. Blood 2002 Oct;100(7):2487-93
    Matsuno H et al
    2002/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 50
  • 文献情報:
    Valc叩rcel M et al. IL-18 regulates melanoma VLA-4 integrin activation through a Hierarchized sequence of inflammatory factors. J. Invest. Dermatol. 2014 Feb;134(2):470-80
    Valc叩rcel M et al
    2014/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 51
  • 文献情報:
    Katsube K et al. Vascular endothelial growth factor (VEGF) gene transfer enhances surgical revascularization of necrotic bone. J. Orthop. Res. 2005 Mar;23(2):469-74
    Katsube K et al
    2005/01/01
  • 備考:
    Species: Rabbit, Applications: IHC
  • 参照:
    PubMed
  • No.: 52
  • 文献情報:
    Banerjee K et al. CXCR2-/- mice show enhanced susceptibility to herpetic stromal keratitis: a role for IL-6-induced neovascularization. J. Immunol. 2004 Jan;172(2):1237-45
    Banerjee K et al
    2004/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 53
  • 文献情報:
    Lee E et al. Breast cancer cells condition lymphatic endothelial cells within pre-metastatic niches to promote metastasis. Nat Commun 2014;5:4715
    Lee E et al
    2014/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 54
  • 文献情報:
    Nishida Y et al. Vascularization via activation of VEGF-VEGFR signaling is essential for peripheral nerve regeneration. Biomed. Res. 2018;39(6):287-294
    Nishida Y et al
    2018/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 55
  • 文献情報:
    Schrand B et al. Hapten-mediated recruitment of polyclonal antibodies to tumors engenders antitumor immunity. Nat Commun 2018 08;9(1):3348
    Schrand B et al
    2018/01/01
  • 備考:
    Species: Mouse, Applications: IHC
  • 参照:
    PubMed
  • No.: 56
  • 文献情報:
    Hendel A et al. Granzyme B releases vascular endothelial growth factor from extracellular matrix and induces vascular permeability. Lab. Invest. 2014 Jul;94(7):716-25
    Hendel A et al
    2014/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 57
  • 文献情報:
    Kim B et al. Application of plasmid DNA encoding IL-18 diminishes development of herpetic stromal keratitis by antiangiogenic effects. J. Immunol. 2005 Jul;175(1):509-16
    Kim B et al
    2005/01/01
  • 備考:
    Species: Mouse, Applications: ELISA Development
  • 参照:
    PubMed
  • No.: 58
  • 文献情報:
    Chyou S et al. Fibroblast-type reticular stromal cells regulate the lymph node vasculature. J. Immunol. 2008 Sep;181(6):3887-96
    Chyou S et al
    2008/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 59
  • 文献情報:
    Bonapace L et al. Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis. Nature 2014 Nov;515(7525):130-3
    Bonapace L et al
    2014/01/01
  • 備考:
    Species: Mouse, Applications:
  • 参照:
    PubMed
  • No.: 60
  • 文献情報:
    Cahill RA et al. Mast cells facilitate local VEGF release as an early event in the pathogenesis of postoperative peritoneal adhesions. Surgery 2006 Jul;140(1):108-12
    Cahill RA et al
    2006/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 61
  • 文献情報:
    Adrian-Segarra JM et al. The AB loop of oncostatin M (OSM) determines species-specific signaling in humans and mice. J. Biol. Chem. 2018 12;293(52):20181-20199
    Adrian-Segarra JM et al
    2018/01/01
  • 備考:
    Species: Human, Applications: Western Blot
  • 参照:
    PubMed
  • No.: 62
  • 文献情報:
    Shchors K et al. The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1beta. Genes Dev. 2006 Sep;20(18):2527-38
    Shchors K et al
    2006/01/01
  • 備考:
    Species: Mouse, Applications: ELISA Development
  • 参照:
    PubMed
  • No.: 63
  • 文献情報:
    Nakayama T et al. Regeneration-associated cell transplantation contributes to tissue recovery in mice with acute ischemic stroke. PLoS ONE 2019;14(1):e0210198
    Nakayama T et al
    2019/01/01
  • 備考:
    Species: Mouse, Applications: IHC
  • 参照:
    PubMed
  • No.: 64
  • 文献情報:
    Kodama I et al. Estrogen regulates the production of VEGF for osteoclast formation and activity in op/op mice. J. Bone Miner. Res. 2004 Feb;19(2):200-6
    Kodama I et al
    2004/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 65
  • 文献情報:
    John B et al. Regulation of the bi-directional cross-talk between ovarian cancer cells and adipocytes by SPARC. Oncogene 2019 May;38(22):4366-4383
    John B et al
    2019/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 66
  • 文献情報:
    Pushpakumar SB et al. Folic acid mitigates angiotensin-II-induced blood pressure and renal remodeling. PLoS ONE 2013;8(12):e83813
    Pushpakumar SB et al
    2013/01/01
  • 備考:
    Species: Mouse, Applications: Western Blot
  • 参照:
    PubMed
  • No.: 67
  • 文献情報:
    Kajiya K et al. Vascular endothelial growth factor-A mediates ultraviolet B-induced impairment of lymphatic vessel function. Am. J. Pathol. 2006 Oct;169(4):1496-503
    Kajiya K et al
    2006/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 68
  • 文献情報:
    Lu H et al. IKK2 inhibition attenuates laser-induced choroidal neovascularization. PLoS ONE 2014;9(1):e87530
    Lu H et al
    2014/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 69
  • 文献情報:
    Sun JL et al. Intrafibrillar silicified collagen scaffold modulates monocyte to promote cell homing, angiogenesis and bone regeneration. Biomaterials 2017 01;113:203-216
    Sun JL et al
    2017/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 70
  • 文献情報:
    Wilgus TA et al. Regulation of scar formation by vascular endothelial growth factor. Lab. Invest. 2008 Jun;88(6):579-90
    Wilgus TA et al
    2008/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 71
  • 文献情報:
    Tashiro Y et al. Inhibition of PAI-1 induces neutrophil-driven neoangiogenesis and promotes tissue regeneration via production of angiocrine factors in mice. Blood 2012 Jun;119(26):6382-93
    Tashiro Y et al
    2012/01/01
  • 備考:
    Species: Mouse, Applications: In Vivo
  • 参照:
    PubMed
  • No.: 72
  • 文献情報:
    Limani P et al. Antihypoxic Potentiation of Standard Therapy for Experimental Colorectal Liver Metastasis through Myo-Inositol Trispyrophosphate. Clin. Cancer Res. 2016 Dec;22(23):5887-5897
    Limani P et al
    2016/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 73
  • 文献情報:
    Saint-Geniez M et al. Role of cell and matrix-bound VEGF isoforms in lens development. Invest. Ophthalmol. Vis. Sci. 2009 Jan;50(1):311-21
    Saint-Geniez M et al
    2009/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 74
  • 文献情報:
    Wang H et al. Retinal pigment epithelial cell expression of active Rap 1a by scAAV2 inhibits choroidal neovascularization. Mol Ther Methods Clin Dev 2016;3:16056
    Wang H et al
    2016/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 75
  • 文献情報:
    Li Z et al. IL-17 and VEGF are necessary for efficient corneal nerve regeneration. Am. J. Pathol. 2011 Mar;178(3):1106-16
    Li Z et al
    2011/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 76
  • 文献情報:
    Park SY et al. HMGB1 induces angiogenesis in rheumatoid arthritis via HIF-1&#x3B1; activation. Eur. J. Immunol. 2015 Apr;45(4):1216-27
    Park SY et al
    2015/01/01
  • 備考:
    Species: Mouse, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 77
  • 文献情報:
    Wuest TR et al. VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis. J. Exp. Med. 2010 Jan;207(1):101-15
    Wuest TR et al
    2010/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 78
  • 文献情報:
    Khabbazi S et al. Morphine decreases the pro-angiogenic interaction between breast cancer cells and macrophages in vitro. Sci Rep 2016 Aug;6:31572
    Khabbazi S et al
    2016/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 79
  • 文献情報:
    Morita A et al. A delay in vascularization induces abnormal astrocyte proliferation and migration in the mouse retina. Dev. Dyn. 2017 03;246(3):186-200
    Morita A et al
    2017/01/01
  • 備考:
    Species: Mouse, Applications: IHC-Fr
  • 参照:
    PubMed
  • No.: 80
  • 文献情報:
    Sulaiman RS et al. A novel small molecule ameliorates ocular neovascularisation and synergises with anti-VEGF therapy. Sci Rep 2016 May;6:25509
    Sulaiman RS et al
    2016/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 81
  • 文献情報:
    Kragl M et al. The biomechanical properties of an epithelial tissue determine the location of its vasculature. Nat Commun 2016 Dec;7:13560
    Kragl M et al
    2016/01/01
  • 備考:
    Species: Mouse, Applications: IHC
  • 参照:
    PubMed